Potassium%25252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252525252520chloride

# Potassium Chloride ## Overview Potassium chloride (KCL) is an essential electrolyte that plays a crucial role in nerve impulse transmission, muscle contraction, and maintaining acid-base balance. ## Primary Indications * Treatment and prevention of hypokalemia. * Adjunct therapy in digitalis intoxication. ## Adult Dosing * **Oral:** * For hypokalemia: Typically 20-100 mEq per day in 2-4 divided doses. * Maintenance: 20-40 mEq per day. * Maximum recommended dose for oral supplementation is typically 100-150 mEq per day, but may be higher under strict medical supervision. * **Intravenous (IV):** * For hypokalemia: 10-40 mEq per dose, added to a compatible IV fluid. * Maximum infusion rate: Generally **10-20 mEq/hour** in peripheral lines; may be higher (up to 40 mEq/hour) in central lines with continuous cardiac monitoring, depending on severity of hypokalemia and institutional protocol. * Maximum single dose: Typically **40 mEq** per dose in peripheral IVs. * Total daily dose: Generally **150-200 mEq**, but can be higher with close monitoring. * **Note:** IV potassium administration must be done with extreme caution and continuous cardiac monitoring, especially when infusing at rates >10 mEq/hour or in patients with cardiac disease or renal impairment. ## Pediatric Dosing * **Oral:** * Maintenance: 1-2 mEq/kg/day in 2-4 divided doses, not to exceed 100 mEq/day. * **Intravenous (IV):** * For hypokalemia: 0.3-0.5 mEq/kg/dose, added to a compatible IV fluid. * Maximum infusion rate: Generally **0.2 mEq/kg/hour** (up to 1 mEq/kg/hour in emergencies with cardiac monitoring), depending on patient's age, weight, and severity of hypokalemia. * Maximum concentration: Typically **40 mEq/L** in peripheral IVs; can be higher (up to 80 mEq/L) in central IVs with continuous cardiac monitoring. * **Note:** Pediatric IV potassium administration requires careful calculation and continuous monitoring. Consult pediatric specific guidelines or protocols. ## Dose Adjustments * **Renal Impairment:** Reduce dose significantly or avoid use. Potassium is renally excreted. * **Adrenal Insufficiency:** May require lower doses. ## Contraindications * Severe renal impairment. * Conditions where hyperkalemia is present or may develop (e.g., anuria, oliguria, severe untreated Addison's disease, decerebration, certain muscle dystrophies). * Untreated Addison's disease. * Known hypersensitivity to potassium chloride. ## Adverse Effects * **Common:** Nausea, vomiting, abdominal pain, diarrhea. * **Serious:** * **Hyperkalemia:** (Life-threatening) Symptoms include paresthesias, weakness, paralysis, cardiac arrhythmias, cardiac arrest. Risk is increased with rapid infusion, high doses, renal impairment, and concurrent use of potassium-sparing drugs. * **Gastrointestinal ulceration, bleeding, or perforation:** Especially with sustained-release oral formulations. ## Key Drug Interactions * **Potassium-Sparing Diuretics (e.g., spironolactone, amiloride, triamterene):** Increased risk of hyperkalemia. * **ACE Inhibitors (ACEIs) and Angiotensin Receptor Blockers (ARBs):** Increased risk of hyperkalemia. * **NSAIDs:** May impair potassium excretion, increasing risk of hyperkalemia. * **Heparin:** May cause hyperkalemia by inhibiting aldosterone production. * **Digoxin:** Hypokalemia enhances digoxin toxicity. Conversely, hyperkalemia reduces digoxin's therapeutic effect and toxicity. * **Neuromuscular Blocking Agents:** Potassium can affect neuromuscular blockade. ## Monitoring * **Serum Potassium Levels:** Frequently, especially during IV administration, dose adjustments, or with concurrent interacting medications. * **Renal Function:** Monitor BUN and creatinine. * **ECG:** Essential during rapid or high-dose IV potassium administration, particularly in patients with cardiac risk factors. * **Signs and symptoms of hyperkalemia or hypokalemia.** ## Clinical Pearls * Always dilute IV potassium chloride in a compatible IV solution (e.g., NS, D5W) before administration. Never administer IV potassium undiluted. * Oral potassium chloride can be irritating to the GI tract; instruct patients to take with food or a large glass of water. * Sustained-release formulations may reduce GI irritation but can still cause problems. * Rapid IV infusion of potassium can cause phlebitis and potentially life-threatening cardiac arrhythmias. * Correcting severe hypokalemia may require aggressive IV administration, but this must be done with extreme caution and continuous cardiac monitoring. *** **Disclaimer:** This information is intended for healthcare professionals. Always consult the most current prescribing information, institutional protocols, and patient-specific factors before making clinical decisions.